Cargando…
Exploring extracellular vesicles as mediators of clinical disease and vehicles for viral therapeutics: Insights from the COVID-19 pandemic
The COVID-19 pandemic has challenged researchers to rapidly understand the capabilities of the SARS-CoV-2 virus and investigate potential therapeutics for SARS-CoV-2 infection. COVID-19 has been associated with devastating lung and cardiac injury, profound inflammation, and a heightened coagulopathi...
Autores principales: | Craddock, Vaughn D., Cook, Christine M., Dhillon, Navneet K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348627/ https://www.ncbi.nlm.nih.gov/pubmed/35929616 http://dx.doi.org/10.20517/evcna.2022.19 |
Ejemplares similares
-
Extracellular vesicle‐mediated endothelial apoptosis and EV‐associated proteins correlate with COVID‐19 disease severity
por: Krishnamachary, Balaji, et al.
Publicado: (2021) -
The Potential Role of Extracellular Vesicles in COVID-19 Associated Endothelial injury and Pro-inflammation
por: Krishnamachary, Balaji, et al.
Publicado: (2020) -
Extracellular Vesicles: Biomarkers, Therapeutics, and Vehicles in the Visual System
por: van der Merwe, Yolandi, et al.
Publicado: (2017) -
Correction to: Extracellular Vesicles: Biomarkers, Therapeutics, and Vehicles in the Visual System
por: van der Merwe, Yolandi, et al.
Publicado: (2018) -
Extracellular vesicles: novel communicators in lung diseases
por: Mohan, Aradhana, et al.
Publicado: (2020)